Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-16

Clinical Trial Update: Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing repetitive transcranial magnetic stimulation (rTMS) for central neuropathic pain in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Repetitive transcranial magnetic stimulation (repetitive transcranial magnetic stimulation)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Multiple Sclerosis With Central Neuropathic Pain | Phase 3 | Status: UNKNOWN